Heritage and Dexcel sign exclusive agreement for extended release ANDA product

Heritage generics deal

Heritage Pharmaceuticals Inc. has signed an Exclusive Development, Supply & Distribution Agreement with Dexcel Ltd. for an Extended Release ANDA drug product. Dexcel will be responsible for the development, registration and manufacturing of the product, and Heritage Pharmaceuticals will be responsible for marketing and distribution in the US. The product generates generic annual US sales of approximately $60 million, per IMS Health.

Read the source article at MarketWatch

About the Author

Leave a Reply